Replies to post #78346 on Ocata Therapeutics Inc fka OCAT

[farviewhill]

Sure would have been nice with all his 'smarts' and 'connections', if Langer had better guided Wotton on his apparent aborted, ill timed secondary and uplisting.
But wait, perhaps they're not really speaking or really working together for the good of the company.
These guys are known to have super egos you know.

And what about all the other 'hot shot and esteemed' advisory members?
Where were they when we needed them?
Oh, I know, they are are part of this new 'ruthless' window dressing which Wotton so gleefully touted when he was giving away more of our equity without having anything he's done to date, that we can see, to truly have earned that privilege.

No, I'm not bashing.
We're still a 'penny stock'
Were still heavily and daily manipulated.
We're still on the otcbb and the prospects for uplisting are questionable at best.
Because we need to sell more shares and apparently there are no takers.
So much for Wotton and all his advisors.
We have something like three months operating capital left. Sounds pretty dire to me.
Suggests to me either a jv or a much, much lower share price is in the cards for the new shares being pedaled.

I don't think any of this is being unfair, just honest and realistic.

[Dragon Lady]

"OCAT "Therapeutics" board-member Robert Langer "

Wiki?

Well, he jointed the ACTC (OCAT) board in 2011, brought on by CEO Gary Rabin (That's Rabin of SEC violation and conviction fame).

Apparently the BOD was not "hands on" or monitoring the company activities and day to day business close enough IMO, to keep their CEO from committing SEC violations, leading to SEC prosecution, fines, the exit of the CEO, etc?

What was the stock price and company value in 2011 when Langer got a BOD seat and what's it at today? Looks like while he was a BOD member, the stock diluted out to past 3 BILLION shares, was a solid OTC penny stock and sold for at least as low as 5 cents a share. Not bad I guess?

Normally, BOD positions are essentially just paid spots, handsomely paid to lend their name and potential connections to a BOD, show up and meet a few times a yr at the most, etc.

Celebs, former astronauts, political figures etc often sit on BOD's for large companies, getting paid easy money to lend their names, status, connections, etc. It's good money for a few meetings a year.

I'd need to look at their 10-K to find out what Langer and others are getting paid in annual compensation and more than likely shares of stock, options, etc for their BOD participation. It'll be in the SEC filings somewhere. I might check it out later.